SCHEMBL29934205

SCHEMBL29934205

O=c1[nH]c(=O)n(O)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DAO P14920 11/20 0.60
FEN1 P39748 3/20 0.52
ERCC5 P28715 2/20 0.52
CA12 O43570 1/20 0.52
RNASEH1 O60930 1/20 0.52
ERCC1 P07992 1/20 0.52
CA9 Q16790 1/20 0.52
ERCC4 Q92889 1/20 0.52
LCK P06239 1/20 0.44
PRKACA P17612 1/20 0.44
CSNK2A2 P19784 1/20 0.44
PRKACG P22612 1/20 0.44
PRKACB P22694 1/20 0.44
GSK3B P49841 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
DYRK1A Q13627 1/20 0.44
CSNK2A3 Q8NEV1 1/20 0.44
KDM4E B2RXH2 1/20 0.43
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4558163 1.00 DAO (0.60) DAOFEN1ERCC5CA12RNASEH1
SCHEMBL9280731 0.81 KDM4E (0.45) DAOFEN1ERCC5CA12RNASEH1
SCHEMBL1382913 0.76 PARP1 (0.42) DAOCA12CA9LCKPRKACA
SCHEMBL19673966 0.76 ALDH1A1 (0.52) DAOCA12CA9LCKPRKACA
SCHEMBL5033267 0.76 GPR3 (0.52) DAOFEN1CA12ERCC1CA9
SCHEMBL27888984 0.76 LCK (0.48) DAOLCKPRKACACSNK2A2PRKACG
SCHEMBL31741258 0.75 DAO (1.00) DAOFEN1ERCC5CA12RNASEH1
SCHEMBL7735923 0.75 DAO (1.00) DAOFEN1ERCC5CA12RNASEH1
SCHEMBL17501689 0.74 PKM (0.42) DAOCA12CA9LCKPRKACA
Benzene SCHEMBL28335868 0.74 ADORA3 (0.50) DAOFEN1ERCC1ERCC4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3353154-B3 3-HYDROXY-7-(SULFONYL)QUINAZOLINE-2,4(1H,3H)-DIONE AND 3-HYDROXY-PYRIDO[2,3-D]PYRIMIDINE-2,4(1H,3H)-DIONE DERIVATIVES AND RELATED COMPOUNDS AS FLAP-ENDONUCLEASE 1 (FEN-1) INHIBITORS FOR USE IN CANCER THERAPY LUDWIG INST FOR CANCER RES LTD (CH) 2022-10-19 EP disclosed